Study Summary
This trial is testing whether an evidence-based intervention can help prevent excessive weight gain during and after pregnancy, when delivered through a national home visiting organization. If successful, the intervention could have a significant impact on obesity and related chronic diseases.
Treatment Effectiveness
Effectiveness Progress
Study Objectives
1 Primary · 1 Secondary · Reporting Duration: throughout intervention delivery, which can range from 2-4 years for parent educators depending on when their site is randomized
Trial Safety
Safety Progress
Trial Design
2 Treatment Groups
Usual Care
1 of 2
HEALTH-P2
1 of 2
Active Control
Experimental Treatment
784 Total Participants · 2 Treatment Groups
Primary Treatment: HEALTH-P2 · No Placebo Group · Phase 2
Trial Logistics
Trial Timeline
Who is running the clinical trial?
Eligibility Criteria
Age 18+ · All Participants · 8 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you:Who else is applying?
What state do they live in?
| Missouri | 100.0% |
What site did they apply to?
| Washington University in St. Louis | 100.0% |
What portion of applicants met pre-screening criteria?
| Met criteria | 100.0% |
Why did patients apply to this trial?
- "I had never been on weight loss drugs. I have gone fron 216 to 195 in the past year and i am interested in checking out thr trial"
How many prior treatments have patients received?
| 0 | 100.0% |
Frequently Asked Questions
Are there any vacancies available for this clinical study?
"Affirmative. According to information posted on clinicaltrials.gov, the trial is currently recruiting participants and was initially listed on February 3rd 2020 with its last update taking place on October 28th 2022. This research endeavour requires 784 patients across a single site." - Anonymous Online Contributor
How many individuals have signed up to partake in this experiment?
"Affirmative. According to clinicaltrials.gov, this clinical trial is actively seeking participants and has been since February 3rd 2020. The listing was last updated on October 28th 2022 and 784 people across a single site are required for enrolment purposes." - Anonymous Online Contributor
What potential risks do patients face when using HEALTH-P2?
"Although preliminary evidence exists of HEALTH-P2's safety, efficacy has yet to be substantiated. Therefore, our team at Power rated the drug a 2 on their 1-3 scale." - Anonymous Online Contributor